Clinical Trials Using Anti-CTGF Monoclonal Antibody FG-3019
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-CTGF Monoclonal Antibody FG-3019. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
-
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Locally Advanced Pancreatic Cancer
This is a Phase 3, randomized, double-blind trial to evaluate the efficacy and safety of neoadjuvant treatment with pamrevlumab or placebo in combination with either gemcitabine plus nab-paclitaxel (G / NP) or FOLFIRINOX in the treatment of locally advanced, unresectable pancreatic cancer subjects.
Location: 15 locations